Feedback / Questions
ATYR2810 - aTyr Pharma
https://www.globenewswire.com/news-release/2022/04/11/2419992/0/en/aTyr-Pharma-Presents-Preclinical-Research-Characterizing-Effects-of-ATYR2810-in-Highly-Aggressive-Tumor-Subtypes-at-the-2022-AACR-Annual-Meeting.html
Apr 11, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next